Literature DB >> 22475756

Pituitary tumor-transforming gene 1 enhances proliferation and suppresses early differentiation of keratinocytes.

Yosuke Ishitsuka1, Yasuhiro Kawachi, Shijima Taguchi, Hiroshi Maruyama, Yasuhiro Fujisawa, Junichi Furuta, Yasuhiro Nakamura, Fujio Otsuka.   

Abstract

The epidermis is a self-renewing tissue, the homeostasis of which is dependent upon the tight balance between proliferation and differentiation based on appropriate regulation of the cell cycle. The cell cycle regulation is dependent on the interactions among a number of cell cycle regulatory molecules, including the pituitary tumor-transforming gene 1 (PTTG1), also known as securin, a regulator of sister chromatid separation and transition from metaphase to anaphase. This study was conducted to clarify the less-known functions of PTTG1 in the epidermis by the use of keratinocytes cultured under two-dimensional (2D) or three-dimensional (3D) conditions. Forced overexpression of PTTG1 caused upregulation of cyclin B1, cyclin-dependent kinase 1 (CDK1), and c-Myc, resulting in enhanced proliferation and suppression of early differentiation without apparent alterations in terminal differentiation, and the exogenous PTTG1 was downregulated in association with cell cycle exit. In contrast, depletion of PTTG1 caused their downregulation and constrained proliferation with retention of differentiation capacity. These findings suggested that PTTG1 could alter the proliferation status by modulating the expression levels of the other cell cycle regulatory proteins, and excess PTTG1 primarily affects early differentiation of keratinocytes under the stability regulation associated with cell cycle exit.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22475756     DOI: 10.1038/jid.2012.74

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

1.  Enucleation-induced rat adrenal gland regeneration: expression profile of selected genes involved in control of adrenocortical cell proliferation.

Authors:  Marianna Tyczewska; Marcin Rucinski; Agnieszka Ziolkowska; Marta Szyszka; Marcin Trejter; Anna Hochol-Molenda; Krzysztof W Nowak; Ludwik K Malendowicz
Journal:  Int J Endocrinol       Date:  2014-11-06       Impact factor: 3.257

2.  The Adhesion G-Protein-Coupled Receptor GPR115/ADGRF4 Regulates Epidermal Differentiation and Associates with Cytoskeletal KRT1.

Authors:  Romy Winkler; Marianne Quaas; Stefan Glasmacher; Uwe Wolfrum; Torsten Thalheim; Jörg Galle; Knut Krohn; Thomas M Magin; Gabriela Aust
Journal:  Cells       Date:  2022-10-07       Impact factor: 7.666

3.  PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma.

Authors:  Jacqueline E Noll; Kate Vandyke; Duncan R Hewett; Krzysztof M Mrozik; Rachel J Bala; Sharon A Williams; Chung H Kok; Andrew Cw Zannettino
Journal:  J Hematol Oncol       Date:  2015-10-06       Impact factor: 17.388

4.  Down-regulation of the oncogene PTTG1 via the KLF6 tumor suppressor during induction of myeloid differentiation.

Authors:  Pei-Yi Chen; Jui-Hung Yen; Ruey-Ho Kao; Ji-Hshiung Chen
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

5.  Defining the cellular lineage hierarchy in the interfollicular epidermis of adult skin.

Authors:  Aiko Sada; Fadi Jacob; Eva Leung; Sherry Wang; Brian S White; David Shalloway; Tudorita Tumbar
Journal:  Nat Cell Biol       Date:  2016-05-16       Impact factor: 28.824

6.  PTTG1 is involved in TNF-α-related hepatocellular carcinoma via the induction of c-myc.

Authors:  Xianyi Lin; Yidong Yang; Yunwei Guo; Huiling Liu; Jie Jiang; Fengping Zheng; Bin Wu
Journal:  Cancer Med       Date:  2019-08-06       Impact factor: 4.452

7.  Single cell transcriptomics of human epidermis identifies basal stem cell transition states.

Authors:  Shuxiong Wang; Michael L Drummond; Christian F Guerrero-Juarez; Eric Tarapore; Adam L MacLean; Adam R Stabell; Stephanie C Wu; Guadalupe Gutierrez; Bao T That; Claudia A Benavente; Qing Nie; Scott X Atwood
Journal:  Nat Commun       Date:  2020-08-25       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.